RAC 1.11% $1.83 race oncology ltd

Ann: H1 2023 Preclinical and Clinical Programs Update, page-103

  1. 8,371 Posts.
    lightbulb Created with Sketch. 1379
    So how did existing cardioprotective drugs get approved? What was the control arm in their trials?
    They must have found a way to measure cardiotoxicity in the control arm.
    AFAIK this data would be public.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.